Browse > Article

Expression of Estrogen and Progesterone Receptors in Non-small-cell Lung Cancer Tissue Using Tissue Microarray Method  

Han, Hye-Seung (Department of Pathology, College of Medicine, Konkuk University)
Kim, Min-Ji (Department of Internal Medicine, College of Medicine, Inha University)
Cho, Jae-Hwa (Department of Internal Medicine, College of Medicine, Inha University)
Yoon, Yong-Han (Department of Chest Surgery, College of Medicine, Inha University)
Kwak, Seung-Min (Department of Internal Medicine, College of Medicine, Inha University)
Lee, Hong-Lyeol (Department of Internal Medicine, College of Medicine, Inha University)
Kim, Kwang-Ho (Department of Chest Surgery, College of Medicine, Inha University)
Ryu, Jeong-Seon (Department of Internal Medicine, College of Medicine, Inha University)
Publication Information
Tuberculosis and Respiratory Diseases / v.58, no.1, 2005 , pp. 54-58 More about this Journal
Abstract
Background : To evaluate the role of estrogen and progesterone in the carcinogenesis of NSCLC, IHC studies for the expression of the receptors of estrogen and progesterone have been performed with inconsistent results. Recently the TMA method has been developed and has become recognized as a useful and rapid method for extensively analysing molecular markers at the gene and protein level. We have investigated their expressions in the tissue from NSCLC using the microarray method. Methods : The TMA construction was made with 70 formalinfixed, paraffin-embedded tissues of NSCLC. After heat-induced epitope retrieval, IHC staining on primary tissues of NSCLC was performed with the monoclonal antibodies, ER1D5 and PR1A6. Results : Our sample of 70 consisted of 74% men and 26% women. Of the patients, 49% were current smokers, 27% were non-smokers and 24% were former smokers. By histologic classification, 34 patients had squamous cell carcinoma, 24 had adenocarcinoma, 9 had adenosquamous cell carcinoma, and 3 had other carcinomas. No cancer cells were immunostained with these monoclonal antibodies in any primary tissues of NSCLC. Conclusions : No expression of neither of the two receptors was found in any of the lung cancer tissues. This suggests that adequate genetic variants for IHC staining need to be developed for NSCLC.
Keywords
Lung Cancer; Receptor; Estrogen; Progesterone;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Stein B, Dougherty D, Takita H, Antkowiak J, Kunz J, van Ragha D. Bronchogenic carcinoma in patients (pts) aged less than 40 years: changing demography. Proc Annu Meet Am Soc Clin Oncol 1993;12:A1141
2 Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst 1996;88:183-92   DOI   PUBMED
3 Omoto Y, Kobayashi Y, Nishida K, Tsuchiya E, Eguchi H, Nakagawa K, et al. Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers. Biochem Biophys Res Commun 2001;285:340-7   DOI   PUBMED   ScienceOn
4 Bubendorf L, Nocito A, Moch H, Sauter G. Tissue microarray (TMA) technology: miniaturized pathology archives for highthroughput in situ studies. J Pathol 2001;195:72-9   DOI   ScienceOn
5 Baron JA, la Vecchia C, Levi F. The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol 1990;162:502-14   DOI   ScienceOn
6 Werner M, Chott A, Fabiano A, Battifora H. Effect of formalin tissue fixation and processing on immunohistochemistry. Am J Surg Pathol 2000;24:1016-9   DOI   ScienceOn
7 Taioli E, Wynder EL. Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 1994;86:869-70   DOI   ScienceOn
8 Canver CC, Memoli VA, Vanderveer PL, Dingivan CA, Mentzer RM Jr. Sex hormone receptors in nonsmall-cell lung cancer in human beings. J Thorac Cardiovasc Surg 1994;108:153-7
9 Su JM, Hsu HK, Chang H, Lin SL, Chang HC, Huang MS, et al. Expression of estrogen and progesterone receptors in non-small-cell lung cancer: immunohistochemical study. Anticancer Res 1996;16:3803-6
10 Farrell PM. Fetal lung development and the influence of glucocorticoids on plmonary surfactant. J Steroid Biochem 1977;8:463-70   DOI   PUBMED   ScienceOn
11 Radzikowska E, Langfort R, Giedronowicz D. Estrogen and progesterone receptors in non small cell lung cancer patients. Ann Thorac Cardiovasc Surg 2002;8:69-73
12 Dresler CM, Fratelli C, Babb J, Everley L, Evans AA, Clapper ML. Gender differences in genetic susceptibility for lung cancer. Lung Cancer 2000;30:153-60   DOI   ScienceOn
13 Vargas SO, Leslie KO, Vacek PM, Socinski MA, Weaver DL. Estrogen-receptor-related protein p29 in primary non-small cell lung carcinoma: pathologic and prognostic correlations. Cancer 1998;82:1495-500   DOI   PUBMED   ScienceOn
14 Shriver SP, Bourdeau HA, Gubish CT, Tirpak DL, Davis AL, Luketich JD, et al. Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer. J Natl Cancer Inst 2000;92:24-33   DOI   ScienceOn
15 Mendelson CR, MacDonald PC, Johnston JM. Estrogen binding in human fetal lung tissue cytosol. Endocrinology 1980;106:368-74   DOI   ScienceOn
16 Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-7   DOI   ScienceOn
17 Cagle PT, Mody DR, Schwartz MR. Estrogen and progesterone receptors in bronchogenic carcinoma. Cancer Res 1990;50:6632-5
18 Kim WH. Tissue array method for large scale clinicopathologic study. Korean J Pathol 2002;36:199-204
19 di Nunno L, Larsson LG, Rinehart JJ, Beissner RS. Estrogen and progesterone receptors in non-small cell lung cancer in 248 consecutive patients who underwent surgical resection. Arch Pathol Lab Med 2000;124:1467-70
20 Kern JA, Filderman AE. Oncogenes and growth factors in human lung cancer. Clin Chest Med 1993;14:31-41
21 Stabile LP, Davis AL, Gubish CT, Hopkins TM, Luketich JD, Christie N, et al. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor ${\alpha}\;and\;{\beta}$ and show biological responses to estrogen. Cancer Res 2002;62:2141-50
22 Ollayos CW, Riordan GP, Rushin JM. Estrogen receptor detection in paraffin sections of adenocarcinoma of the colon, pancreas, and lung. Arch Pathol Lab Med 1994;118:630-2
23 Dabbs DJ, Landreneau RJ, Liu Y, Raab SS, Maley RH, Tung MY, et al. Detection of estrogen receptor by immunohistochemistry in pulmonary adenocarcinoma. Ann Thorac Surg 2002;73:403-6   DOI   ScienceOn
24 Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-7   DOI   PUBMED   ScienceOn